Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-06-02 19:50:07 ET · period of report 2026-05-29 · accession 0001547959-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 19:50 | 2026-05-29 | MIRM | Ramasastry Saira | Dir | M - OptEx | — | +3,977 | 3,977 | New | — |
| D | 2026-06-02 19:50 | 2026-06-01 | MIRM | Ramasastry Saira | Dir | S - Sale+OE | $100.00 | -3,977 | 0 | -100% | -$397.7K |
| D | 2026-06-02 19:50 | 2026-05-29 | MIRM | Ramasastry Saira | Dir | M - OptEx | $0.00 | -3,977 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-29 | M | A | 3,977 | — | 3,977 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 2 | Common | Common Stock | 2026-06-01 | S | D | 3,977 | $100.00 | 0 | D | — | — | (F2) Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025. |
| 3 | Derivative | Restricted Stock Units | 2026-05-29 | M | D | 3,977 | $0.00 | 0 | D | — · — to — | 3,977 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests on May 29, 2026. (F3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests on May 29, 2026. |